Arcadia Biosciences, Inc.
RKDA
$0.92
-$0.11-10.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.39M | -1.34M | 856.00K | -4.46M | 2.60M |
| Total Depreciation and Amortization | 8.00K | 2.00K | 7.00K | 28.00K | 117.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.66M | -31.00K | -1.95M | 3.06M | -3.60M |
| Change in Net Operating Assets | -382.00K | 504.00K | 830.00K | -659.00K | -701.00K |
| Cash from Operations | -1.10M | -861.00K | -257.00K | -2.03M | -1.59M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 250.00K | 500.00K |
| Cash from Investing | -- | 0.00 | 0.00 | 250.00K | 500.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 1.00K | 0.00 | 5.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.79M | -- | -- | -- | -- |
| Cash from Financing | 1.79M | 0.00 | 1.00K | 0.00 | 5.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 695.00K | -861.00K | -256.00K | -1.78M | -1.08M |